Gm-csf regulates protein and lipid catabolism by alveolar macrophages

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 3 24-3, 2001, Pages

  Yoshida, Mitsuhiro ^a   Ikegami, Machiko ^a   Reed, Jacquelyn A ^a   Chroneos, Zissis C ^a   Whitsett, Jeffrey A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Granulocyte macrophage colony stimulating factor; Pulmonary alveolar proteinosis

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LUNG SURFACTANT; PROTEIN A; RHODAMINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; LIPOLYSIS; LUNG ALVEOLUS MACROPHAGE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN TRANSPORT;

EID: 0035017255     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.3.l379     Document Type: Article

References (30)

1. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
2. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-260, 1976.
3. Chroneos ZC, Abdolrasulnia R, Whitsett JA, Rice WR, and Shepherd VL. Purification of a cell-surface receptor for surfactant protein A. J Biol Chem 271: 16375-16383, 1996.
4. Chroneos ZC and Shepherd VL. Differential regulation of the mannose and SP-A receptors on macrophages. Am J Physiol Lung Cell Mol Physiol 269: L721-L726, 1995.
5. Cooke KR, Nishinakamura R, Martin TR, Kobzik L, Brewer J, Whitsett JA, Bungard D, Murray R, and Ferrara JLM. Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMT. Bone Marrow Transplant 20: 657-662, 1997.
6. Dirksen U, Nishinakamura R, Groneck P, Hattenhorst U, Nogee L, Murray R, and Burdach S. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/ IL-5 receptor common β chain expression. J Clin Invest 100: 2211-2217, 1997.
7. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, Dickersin GR, Bachurski CJ, Mark EL, Whitsett JA, and Mulligan RC. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713-716, 1994.
8. 3H]palmitate to BSA. Am J Physiol Gastrointest Liver Physiol 275: G638-G644, 1998.
9. Haagsman HP, Hawgood S, Sargeant T, Buckley D, White RT, Drickamer K, and Benson BJ. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J Biol Chem 262: 13877-13880, 1987.
10. Huffman-Reed JA, Rice WR, Zsengellér ZK, Wert SE, Dranoff G, and Whitsett JA. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am J Physiol Lung Cell Mol Physiol 273: L715-L725, 1997.
11. Ikegami M, Ueda T, Hull W, Whitsett JA, Mulligan RC, Dranoff G, and Jobe AH. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol Lung Cell Mol Physiol 270: L650-L658, 1996.
12. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, and Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 158: 4336-4340, 1997.
13. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, and Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 103: 1015-1021, 1999.
14. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, and Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 19: 700-708, 1998.
15. LeVine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, Whitsett JA, and Korfhagen TR. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 20: 279-286, 1999.
16. LeVine AM, Reed JA, Kurak KE, Cianciolo E, and Whitsett JA. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J Clin Invest 103: 563-569, 1999.
17. IL3 receptor-deficient mice are normal. Immunity 2: 211-222, 1995.
18. Pison U, Wright JR, and Hawgood S. Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 262: L412-L417, 1992.
19. Price NC and Dwek RA. Principles and Problems in Physical Chemistry for Biochemists. Oxford, UK: Oxford University Press, 1979, p. 32-44.
20. Reed JA, Ikegami M, Cianciolo ER, Lu W, Cho PS, Hull W, Jobe AH, and Whitsett JA. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol Lung Cell Mol Physiol 276: L556-L563, 1999.
21. Rider ED, Ikegami M, and Jobe AH. Localization of alveolar surfactant clearance in rabbit lung cells. Am J Physiol Lung Cell Mol Physiol 263: L201-L209, 1992.
22. Robb L, Drinkwater CC, Metcalf D, Li R, Kontgen F, Nicola NA, and Begley CG. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci USA 92: 9565-9569, 1995.
23. Sandron D, Reynolds HY, Laval A, Venet A, Israel-Biet D, and Chretien J. Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients. Cytological data in normals and sarcoid patients. Eur J Respir Dis 68: 177-185, 1986.
24. Seymour JF, Begley CG, Dirksen U, Presneill JJ, Nicola NA, Moore PE, Schoch OD, van Asperen P, Roth B, Burdach S, and Dunn AR. Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis. Blood 92: 2657-2667, 1998.
25. Stanley E, Lieshka GJ, Grail D, Metcalf D, Hodgson G, Gall JAM, Maher DW, Cebon J, Sinickas V, and Dunn AR. Granulocyte/macrophage colony stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 91: 5592-5594, 1994.
26. Tanaka N, Watanabe J, Kitamura T, Yamada Y, Kanegasaki S, and Nakata K. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett 442: 246-250, 1999.
27. Tarr PE. Granulocyte-macrophage colony-stimulating factor and the immune system. Med Oncol 13: 133-140, 1996.
28. Tchou-Wong D, Harking TJ, Chi C, Bodkin M, and Rom WN. GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 156: 1999-2002, 1997.
29. Wright JR and Youmans DC. Degradation of surfactant lipids and surfactant protein A by alveolar macrophages in vitro. Am J Physiol Lung Cell Mol Physiol 268: L772-L780, 1995.
30. Zsengeller ZK, Reed JA, Bachurski CJ, LeVine AM, Forry-Schaudies S, Hirsch R, and Whitsett JA. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice. Hum Gene Ther 9: 2101-2109, 1998.